Rankings
▼
Calendar
TARA FY 2017 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$211M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$148,000
Operating Income
-$30M
Net Income
-$30M
EPS (Diluted)
$-69.38
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$925
Balance Sheet
Total Assets
$44M
Total Liabilities
$9M
Stockholders' Equity
$35M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$148,000
-$123,000
-20.3%
Operating Income
-$30M
-$29M
-5.8%
Net Income
-$30M
-$29M
-5.0%
← Q4 2016
All Quarters
Q1 2017 →